Dual therapeutic benefits of selective-histone deacetylase 3 inhibition in Huntington's disease mice
(2016) Workshop of the Institute of Neurosciences of the University of Barcelona — Location: Barcelona, Spain
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- Our findings highlight the promising therapeutic potential of selectively inhibiting histone deacetylase 3 as a strategy to alleviate cognitive symptoms in a Huntington's disease mouse model.
- Affiliations
Universitat de Barcelona
Citations
Suelves Caballol, N., Kirkham-Mccarthy L, Lahue RS, & Ginés S. (2016). Dual therapeutic benefits of selective-histone deacetylase 3 inhibition in Huntington’s disease mice. Workshop of the Institute of Neurosciences of the University of Barcelona, Barcelona, Spain. https://hdl.handle.net/2078.5/238438